Cargando…
The Loss of the p53 Activator HIPK2 Is Responsible for Galectin-3 Overexpression in Well Differentiated Thyroid Carcinomas
BACKGROUND: Galectin-3 (Gal-3) is an anti-apoptotic molecule involved in thyroid cells transformation. It is specifically overexpressed in thyroid tumour cells and is currently used as a preoperative diagnostic marker of thyroid malignancy. Gal-3 expression is downregulated by wt-p53 at the transcri...
Autores principales: | Lavra, Luca, Rinaldo, Cinzia, Ulivieri, Alessandra, Luciani, Emidio, Fidanza, Paolo, Giacomelli, Laura, Bellotti, Carlo, Ricci, Alberto, Trovato, Maria, Soddu, Silvia, Bartolazzi, Armando, Sciacchitano, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117790/ https://www.ncbi.nlm.nih.gov/pubmed/21698151 http://dx.doi.org/10.1371/journal.pone.0020665 |
Ejemplares similares
-
Antiproliferative Effects of 1α-OH-vitD(3) in Malignant Melanoma: Potential Therapeutic implications
por: Spath, Lucia, et al.
Publicado: (2017) -
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
por: Sciacchitano, Salvatore, et al.
Publicado: (2018) -
Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology
por: Sciacchitano, Salvatore, et al.
Publicado: (2017) -
Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives
por: Bartolazzi, Armando, et al.
Publicado: (2018) -
HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity
por: Valente, Davide, et al.
Publicado: (2015)